journal article·2026-05

Dual Single‐Atom Engineered NADH Oxidase‐Mimic Boosts In Situ NAD + Biotransformation for Targeted Myocardial Ischemia/Reperfusion Protection

Jingtao Liu, Xun Guo, Nan Wang, Xingyu Zhang, Xiaoting Wang, Guangru Li, Xumin Hou, Luodan Yu, Yu Chen, Ruogu Li

Advanced Materials· Volume 38· Issue 30
Publisher page

Abstract

ABSTRACT Myocardial ischemia/reperfusion (I/R) injury is a globally recognized pathological condition that results in life‐threatening organ dysfunction. Supplementation with nicotinamide adenine dinucleotide (NAD + ) can improve myocardial energy metabolism, alleviate inflammation, and mitigate I/R injury. However, its clinical applicability is constrained by the poor efficacy and delivery limitations of current NAD + supplementation strategies. Here, we design a dual single‐atom nanozyme with nicotinamide adenine dinucleotide (NADH) oxidase‐mimicking activity for in situ NAD + biotransformation and I/R injury treatment. Upon M2 macrophage membrane coating, the nanozyme selectively targets ischemic myocardium, facilitating in situ NAD + biotransformation by eliminating excess NADH, while concurrently scavenging reactive oxygen species, restoring mitochondrial bioenergetics, attenuating inflammation, and inhibiting apoptosis. Mechanistic investigations demonstrate that the nanozyme activates the NAD + ‐SIRT1 axis, enhancing ATP biosynthesis and oxidative phosphorylation, while suppressing TNF signaling and NF‐κB pathways. Collectively, the engineered NOX‐like nanozyme offers a novel therapeutic strategy for myocardial I/R injury by modulating both mitochondrial bioenergetics and oxidative stress defense pathways through restoring NAD + /NADH homeostasis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Cardiac Ischemia and Reperfusion

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiology Shanghai Chest Hospital Shanghai Jiaotong University School of Medicine China

Department of Ultrasound The First Affiliated Hospital of Chongqing Medical University Chongqing Key Laboratory of Ultrasound Molecular Imaging Chongqing P. R. China

Ultrasound Department of the Second Affiliated Hospital of Chongqing Medical University Chongqing Key Laboratory of Ultrasound Molecular Imaging Chongqing P. R. China

Materdicine Lab School of Life Sciences Shanghai University Shanghai P. R. China

Department of Radiology Shanghai Institute of Thoracic Oncology Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai P. R. China

Funding

National Natural Science Foundation of China

References (67)

Show source-provided references
1. 10.1172/JCI6287410.1172/JCI62874 ↗
2. 10.26599/1671-5411.2023.06.00110.26599/1671-5411.2023.06.001 ↗
3. 10.1038/s41569‐018‐0119‐410.1038/s41569‐018‐0119‐4 ↗
4. 10.1016/j.medj.2023.12.00710.1016/j.medj.2023.12.007 ↗
5. The Pathophysiology of Acute Myocardial Infarction and Strategies of Protection beyond Reperfusion: a Continual Challenge
6. 10.1038/nm.250710.1038/nm.2507 ↗
7. 10.1016/j.tcm.2022.02.00510.1016/j.tcm.2022.02.005 ↗
8. 10.1016/j.bbadis.2020.16576810.1016/j.bbadis.2020.165768 ↗
9. 10.1038/nature1390910.1038/nature13909 ↗
10. 10.1016/j.freeradbiomed.2018.01.02410.1016/j.freeradbiomed.2018.01.024 ↗
11. 10.1016/j.ebiom.2020.10288410.1016/j.ebiom.2020.102884 ↗
12. 10.1016/j.jacbts.2020.02.00410.1016/j.jacbts.2020.02.004 ↗
13. 10.1056/NEJMoa202137210.1056/NEJMoa2021372 ↗
14. 10.1056/NEJMoa240592210.1056/NEJMoa2405922 ↗
15. 10.1056/NEJMoa191238810.1056/NEJMoa1912388 ↗
16. 10.1161/CIRCULATIONAHA.121.05658910.1161/CIRCULATIONAHA.121.056589 ↗
17. 10.1038/nrneph.2017.510.1038/nrneph.2017.5 ↗
18. 10.1016/j.cmet.2015.05.02310.1016/j.cmet.2015.05.023 ↗
19. 10.1038/s41556‐023‐01280‐z10.1038/s41556‐023‐01280‐z ↗
20. 10.1093/nar/gkz12010.1093/nar/gkz120 ↗
21. 10.1089/ars.2017.741510.1089/ars.2017.7415 ↗
22. 10.1126/sciadv.abe531010.1126/sciadv.abe5310 ↗
23. 10.1126/science.aad401710.1126/science.aad4017 ↗
24. 10.1038/s41467‐020‐17242‐010.1038/s41467‐020‐17242‐0 ↗
25. 10.1016/j.cell.2024.05.03410.1016/j.cell.2024.05.034 ↗
26. 10.1016/j.cmet.2014.10.01510.1016/j.cmet.2014.10.015 ↗
27. 10.1038/s41467‐022‐34850‐010.1038/s41467‐022‐34850‐0 ↗
28. 10.1038/s41580‐024‐00752‐w10.1038/s41580‐024‐00752‐w ↗
29. 10.1161/CIRCRESAHA.116.30488110.1161/CIRCRESAHA.116.304881 ↗
30. 10.1016/j.metabol.2024.15604810.1016/j.metabol.2024.156048 ↗
31. 10.1016/j.cell.2006.11.01310.1016/j.cell.2006.11.013 ↗
32. 10.1016/j.cmet.2011.03.00410.1016/j.cmet.2011.03.004 ↗
33. 10.1038/s42255‐023‐00761‐710.1038/s42255‐023‐00761‐7 ↗
34. 10.1016/j.cmet.2012.04.02210.1016/j.cmet.2012.04.022 ↗
35. 10.1126/science.aac485410.1126/science.aac4854 ↗
36. 10.1126/scitranslmed.abd706410.1126/scitranslmed.abd7064 ↗
37. 10.1038/ncomms1310310.1038/ncomms13103 ↗
38. 10.1038/s41467‐024‐45927‐310.1038/s41467‐024‐45927‐3 ↗
39. 10.7150/thno.8354310.7150/thno.83543 ↗
40. 10.1016/j.jare.2024.04.01910.1016/j.jare.2024.04.019 ↗
41. 10.1118/1.315720410.1118/1.3157204 ↗
42. 10.1002/advs.20241451810.1002/advs.202414518 ↗
43. 10.1038/s41467‐019‐08953‐010.1038/s41467‐019‐08953‐0 ↗
44. 10.1038/s41467‐025‐57463‐910.1038/s41467‐025‐57463‐9 ↗
45. 10.1021/acsnano.3c0963910.1021/acsnano.3c09639 ↗
46. 10.1002/anie.20221744910.1002/anie.202217449 ↗
47. 10.1021/jacs.2c1368910.1021/jacs.2c13689 ↗
48. 10.1021/jacs.4c1832810.1021/jacs.4c18328 ↗
49. 10.1002/anie.20191081510.1002/anie.201910815 ↗
50. 10.1038/s41580‐020‐00313‐x10.1038/s41580‐020‐00313‐x ↗
51. 10.1016/j.tcb.2014.04.00210.1016/j.tcb.2014.04.002 ↗
52. 10.1016/j.jacc.2024.02.05610.1016/j.jacc.2024.02.056 ↗
53. 10.1016/j.phrs.2021.10571610.1016/j.phrs.2021.105716 ↗
54. 10.1093/cvr/cvz33610.1093/cvr/cvz336 ↗
55. 10.1161/01.CIR.91.6.187210.1161/01.CIR.91.6.1872 ↗
56. 10.1016/j.lfs.2024.12311910.1016/j.lfs.2024.123119 ↗
57. 10.1093/cvr/cvac13410.1093/cvr/cvac134 ↗
58. 10.3390/v1502035110.3390/v15020351 ↗
59. 10.1016/j.cytogfr.2017.11.00110.1016/j.cytogfr.2017.11.001 ↗
60. 10.1016/j.biopha.2024.11691710.1016/j.biopha.2024.116917 ↗
61. 10.1016/j.mad.2020.11121510.1016/j.mad.2020.111215 ↗
62. 10.1161/CIRCULATIONAHA.122.06173210.1161/CIRCULATIONAHA.122.061732 ↗
63. 10.1016/j.arr.2011.12.00510.1016/j.arr.2011.12.005 ↗
64. 10.1093/cvr/cvn33510.1093/cvr/cvn335 ↗
65. 10.1007/s00011‐004‐1298‐510.1007/s00011‐004‐1298‐5 ↗
66. 10.1038/s41392‐024‐01840‐110.1038/s41392‐024‐01840‐1 ↗
67. 10.1016/j.stem.2021.10.00910.1016/j.stem.2021.10.009 ↗